1. Home
  2. DOX vs STVN Comparison

DOX vs STVN Comparison

Compare DOX & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amdocs Limited

DOX

Amdocs Limited

N/A

Current Price

$58.61

Market Cap

5.6B

Sector

Technology

ML Signal

N/A

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

N/A

Current Price

$19.86

Market Cap

5.7B

ML Signal

N/A

Company Overview

Basic Information
Metric
DOX
STVN
Founded
1982
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
EDP Services
Containers/Packaging
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
5.7B
IPO Year
1998
2021

Fundamental Metrics

Financial Performance
Metric
DOX
STVN
Price
$58.61
$19.86
Analyst Decision
Buy
Buy
Analyst Count
6
13
Target Price
★ $79.25
$24.68
AVG Volume (30 Days)
★ 678.3K
272.0K
Earning Date
11-03-2026
11-05-2026
Dividend Yield
★ 3.98%
0.30%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.66
$7.05
Revenue Next Year
$3.20
$9.26
P/E Ratio
★ $13.65
$27.15
Revenue Growth
N/A
N/A
52 Week Low
$49.74
$12.89
52 Week High
$85.63
$27.99

Technical Indicators

Market Signals
Indicator
DOX
STVN
Relative Strength Index (RSI) 53.21 42.11
Support Level $59.14 $19.16
Resistance Level $64.56 $20.99
Average True Range (ATR) 1.27 0.86
MACD -0.31 -0.13
Stochastic Oscillator 44.16 17.37

Price Performance

Historical Comparison
DOX
STVN

About DOX Amdocs Limited

Amdocs Ltd is a provider of software and services to communications, entertainment, and media service providers. The Company operates in a single segment and designs, develops, markets, supports, implements, and operates open and modular cloud offerings. Its portfolio includes solutions across digital business systems and legacy business and operational support systems, supporting multiple lines of business such as wireless, broadband, cable, fiber, satellite, and digital services. The Company leverages artificial intelligence to support digital transformation, cloud adoption, and intelligent network automation. Geographically, it derives a majority of its revenue from North America and also operates in Europe and the rest of the world.

About STVN Stevanato Group S.p.A.

Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.

Share on Social Networks: